Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (31-40 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 10, 2018
The NISTmAb tryptic peptide spectral library for monoclonal antibody characterizationQian Dong, Yuxue Liang, Xinjian Yan, et al.
Mabs|October 12, 2017
Manufacturing history of etanercept (Enbrel<sup>®</sup>): Consistency of product quality through major process revisionsBrian Hassett, Ena Singh, Ehab Mahgoub, et al.
Mabs|October 10, 2017
Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessmentFrank R Brennan, Joy Cavagnaro, Kathleen McKeever, et al.
Mabs|May 25, 2016
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylationQian Gong, Meredith Hazen, Brett Marshall, et al.
Mabs|March 8, 2018
Analytical comparability study of recombinant monoclonal antibody therapeuticsAlexandre Ambrogelly, Stephen Gozo, Amit Katiyar, et al.
Mabs|February 23, 2018
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal productKyoung Hoon Lee, Jihun Lee, Jin Soo Bae, et al.
Mabs|December 21, 2018
De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanineYue Tong, Xu Fang, Hong Tian, et al.
Mabs|December 21, 2018
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferationEric Hatterer, Leticia Barba, Nelly Noraz, et al.
Mabs|April 16, 2020
Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysisRachel Liuqing Shi, Gang Xiao, Thomas M Dillon, et al.
Mabs|May 26, 2020
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&DSuzanne S Farid, Max Baron, Christos Stamatis, et al.
Pageof 184

Showing results (31-40 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 10, 2018
The NISTmAb tryptic peptide spectral library for monoclonal antibody characterizationQian Dong, Yuxue Liang, Xinjian Yan, et al.
Mabs|October 12, 2017
Manufacturing history of etanercept (Enbrel<sup>®</sup>): Consistency of product quality through major process revisionsBrian Hassett, Ena Singh, Ehab Mahgoub, et al.
Mabs|October 10, 2017
Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessmentFrank R Brennan, Joy Cavagnaro, Kathleen McKeever, et al.
Mabs|May 25, 2016
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylationQian Gong, Meredith Hazen, Brett Marshall, et al.
Mabs|March 8, 2018
Analytical comparability study of recombinant monoclonal antibody therapeuticsAlexandre Ambrogelly, Stephen Gozo, Amit Katiyar, et al.
Mabs|February 23, 2018
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal productKyoung Hoon Lee, Jihun Lee, Jin Soo Bae, et al.
Mabs|December 21, 2018
De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanineYue Tong, Xu Fang, Hong Tian, et al.
Mabs|December 21, 2018
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferationEric Hatterer, Leticia Barba, Nelly Noraz, et al.
Mabs|April 16, 2020
Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysisRachel Liuqing Shi, Gang Xiao, Thomas M Dillon, et al.
Mabs|May 26, 2020
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&DSuzanne S Farid, Max Baron, Christos Stamatis, et al.
Pageof 184